JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 24, 2006; DOI: 10.1124/jpet.106.101832


0022-3565/06/3181-214-222$20.00
JPET 318:214-222, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.101832v1
318/1/214    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Song, Y.
Right arrow Articles by Belardinelli, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Song, Y.
Right arrow Articles by Belardinelli, L.

CARDIOVASCULAR

Blocking Late Sodium Current Reduces Hydrogen Peroxide-Induced Arrhythmogenic Activity and Contractile Dysfunction

Yejia Song, John C. Shryock, Stefan Wagner, Lars S. Maier, and Luiz Belardinelli

Division of Cardiovascular Medicine, University of Florida, Gainesville, Florida (Y.S.); Pharmacological Sciences, CV Therapeutics, Inc., Palo Alto, California (J.C.S., L.B.); and Department of Cardiology and Pneumology, Georg-August-University Göttingen, Göttingen, Germany (S.W., L.S.M.)

Reactive oxygen species (ROS), including H2O2, cause intracellular calcium overload and ischemia-reperfusion damage. The objective of this study was to examine the hypothesis that H2O2-induced arrhythmic activity and contractile dysfunction are the results of an effect of H2O2 to increase the magnitude of the late sodium current (late INa). Guinea pig and rabbit isolated ventricular myocytes were exposed to 200 µM H2O2. Transmembrane voltages and currents and twitch shortening were measured using the whole-cell patch-clamp technique and video edge detection, respectively. [Na+]i and [Ca2+]i were determined by fluorescence measurements. H2O2 caused a persistent late INa that was almost completely inhibited by 10 µM tetrodotoxin (TTX). H2O2 prolonged the action potential duration (APD), slowed the relaxation rate of cell contraction, and induced early afterdepolarizations (EADs) and aftercontractions. H2O2 also caused increases of [Na+]i and [Ca2+]i. Ranolazine (10 µM), a novel inhibitor of late INa, attenuated H2O2-induced late INa by 51 ± 9%. TTX (2 µM) or 10 µM ranolazine attenuated H2O2-induced APD prolongation and suppressed EADs. Ranolazine accelerated the twitch relaxation rate in the presence of H2O2 and abolished H2O2-induced aftercontractions. Pretreatment of myocytes with ranolazine delayed and reduced the increases of APD, [Na+]i, and [Ca2+]i caused by H2O2. In conclusion, the results confirm the hypothesis that an increase in late INa during exposure of ventricular myocytes to H2O2 contributes to electrical and contractile dysfunction and suggest that inhibition of late INa may offer protection against ROS-induced Na+ and Ca2+ overload.


Received January 24, 2006; accepted March 23, 2006.

Address correspondence to: Dr. Yejia Song, Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd., M-411, Gainesville, FL 32610-0277. E-mail: songy{at}medicine.ufl.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Sato, L.-H. Xie, A. A. Sovari, D. X. Tran, N. Morita, F. Xie, H. Karagueuzian, A. Garfinkel, J. N. Weiss, and Z. Qu
Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias
PNAS, March 3, 2009; 106(9): 2983 - 2988.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L.-H. Xie, F. Chen, H. S. Karagueuzian, and J. N. Weiss
Oxidative Stress-Induced Afterdepolarizations and Calmodulin Kinase II Signaling
Circ. Res., January 2, 2009; 104(1): 79 - 86.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Rastogi, V. G. Sharov, S. Mishra, R. C. Gupta, B. Blackburn, L. Belardinelli, W. C. Stanley, and H. N. Sabbah
Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure
Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2149 - H2155.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
W.-Q. Wang, C. Robertson, A. K. Dhalla, and L. Belardinelli
Antitorsadogenic Effects of ({+/-})-N-(2,6-Dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (Ranolazine) in Anesthetized Rabbits
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 875 - 881.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Song, J. C. Shryock, and L. Belardinelli
An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2031 - H2039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. L. Shang, S. Sanyal, A. E. Pfahnl, Z. Jiao, J. Allen, H. Liu, and S. C. Dudley Jr.
NF-{kappa}B-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C372 - C379.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. M. Scirica, D. A. Morrow, H. Hod, S. A. Murphy, L. Belardinelli, C. M. Hedgepeth, P. Molhoek, F. W.A. Verheugt, B. J. Gersh, C. H. McCabe, et al.
Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non ST-Segment Elevation Acute Coronary Syndrome: Results From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) Randomized Controlled Trial
Circulation, October 9, 2007; 116(15): 1647 - 1652.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.